80 related articles for article (PubMed ID: 27602994)
1. Prolactin-Inducible Protein: From Breast Cancer Biomarker to Immune Modulator-Novel Insights from Knockout Mice.
Ihedioha OC; Shiu RP; Uzonna JE; Myal Y
DNA Cell Biol; 2016 Oct; 35(10):537-541. PubMed ID: 27602994
[TBL] [Abstract][Full Text] [Related]
2. The human breast cancer-associated protein, the prolactin-inducible protein (PIP), regulates intracellular signaling events and cytokine production by macrophages.
Ihedioha O; Blanchard AA; Balhara J; Okwor I; Jia P; Uzonna J; Myal Y
Immunol Res; 2018 Apr; 66(2):245-254. PubMed ID: 29536339
[TBL] [Abstract][Full Text] [Related]
3. The prolactin inducible protein/gross cystic disease fluid protein-15 deficient mice develop anomalies in lymphoid organs.
Edechi CA; Nasr MR; Karim A; Blanchard AA; Ellison CA; Qui H; Uzonna JE; Myal Y
Immunobiology; 2019 Nov; 224(6):811-816. PubMed ID: 31447246
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of prolactin-inducible protein leads to impaired Th1 immune response and susceptibility to Leishmania major in mice.
Li J; Liu D; Mou Z; Ihedioha OC; Blanchard A; Jia P; Myal Y; Uzonna JE
Eur J Immunol; 2015 Apr; 45(4):1082-91. PubMed ID: 25594453
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-induced protein in breast cancer.
Naderi A
Adv Exp Med Biol; 2015; 846():189-200. PubMed ID: 25472539
[TBL] [Abstract][Full Text] [Related]
6. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.
Clark JW; Snell L; Shiu RP; Orr FW; Maitre N; Vary CP; Cole DJ; Watson PH
Br J Cancer; 1999 Nov; 81(6):1002-8. PubMed ID: 10576657
[TBL] [Abstract][Full Text] [Related]
7. Generation and initial characterization of the prolactin-inducible protein (PIP) null mouse: accompanying global changes in gene expression in the submandibular gland.
Blanchard A; Nistor A; Castaneda FE; Martin D; Hicks GG; Amara F; Shiu RP; Myal Y
Can J Physiol Pharmacol; 2009 Oct; 87(10):859-72. PubMed ID: 20052012
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene.
Myal Y; Iwasiow B; Yarmill A; Harrison E; Paterson JA; Shiu RP
Endocrinology; 1994 Oct; 135(4):1605-10. PubMed ID: 7925123
[TBL] [Abstract][Full Text] [Related]
9. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells.
Autiero M; Cammarota G; Friedlein A; Zulauf M; Chiappetta G; Dragone V; Guardiola J
Eur J Immunol; 1995 May; 25(5):1461-4. PubMed ID: 7774651
[TBL] [Abstract][Full Text] [Related]
10. Prolactin-Induced Protein regulates cell adhesion in breast cancer.
Vanneste M; Naderi A
Biochem Biophys Res Commun; 2015 Dec; 468(4):850-6. PubMed ID: 26585492
[TBL] [Abstract][Full Text] [Related]
11. The Prolactin Inducible Protein Modulates Antitumor Immune Responses and Metastasis in a Mouse Model of Triple Negative Breast Cancer.
Edechi CA; Ikeogu NM; Akaluka GN; Terceiro LEL; Machado M; Salako ES; Barazandeh AF; Kung SKP; Uzonna JE; Myal Y
Front Oncol; 2021; 11():639859. PubMed ID: 33777801
[TBL] [Abstract][Full Text] [Related]
12. Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications.
Hassan MI; Waheed A; Yadav S; Singh TP; Ahmad F
Cell Mol Life Sci; 2009 Feb; 66(3):447-59. PubMed ID: 18854942
[TBL] [Abstract][Full Text] [Related]
13. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status.
Murphy LC; Lee-Wing M; Goldenberg GJ; Shiu RP
Cancer Res; 1987 Aug; 47(15):4160-4. PubMed ID: 3607757
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-induced protein (PIP)-characterization and role in breast cancer progression.
Urbaniak A; Jablonska K; Podhorska-Okolow M; Ugorski M; Dziegiel P
Am J Cancer Res; 2018; 8(11):2150-2164. PubMed ID: 30555735
[TBL] [Abstract][Full Text] [Related]
15. T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
Knutson KL; Krco CJ; Erskine CL; Goodman K; Kelemen LE; Wettstein PJ; Low PS; Hartmann LC; Kalli KR
J Clin Oncol; 2006 Sep; 24(26):4254-61. PubMed ID: 16908932
[TBL] [Abstract][Full Text] [Related]
16. A functional and regulatory network associated with PIP expression in human breast cancer.
Debily MA; Marhomy SE; Boulanger V; Eveno E; Mariage-Samson R; Camarca A; Auffray C; Piatier-Tonneau D; Imbeaud S
PLoS One; 2009; 4(3):e4696. PubMed ID: 19262752
[TBL] [Abstract][Full Text] [Related]
17. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
Marks E; Verolin M; Stensson A; Lycke N
Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma.
Parris TZ; Kovács A; Aziz L; Hajizadeh S; Nemes S; Semaan M; Forssell-Aronsson E; Karlsson P; Helou K
Int J Cancer; 2014 Apr; 134(7):1617-29. PubMed ID: 24114735
[TBL] [Abstract][Full Text] [Related]
19. Prolactin-induced protein is required for cell cycle progression in breast cancer.
Naderi A; Vanneste M
Neoplasia; 2014 Apr; 16(4):329-42.e1-14. PubMed ID: 24862759
[TBL] [Abstract][Full Text] [Related]
20. Association of Depressed Anti-HER2 T-Helper Type 1 Response With Recurrence in Patients With Completely Treated HER2-Positive Breast Cancer: Role for Immune Monitoring.
Datta J; Fracol M; McMillan MT; Berk E; Xu S; Goodman N; Lewis DA; DeMichele A; Czerniecki BJ
JAMA Oncol; 2016 Feb; 2(2):242-6. PubMed ID: 26719971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
